Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in children 2 months and older is the first FDA-approved mesenchymal stromal ...
Next year’s incoming high school freshmen will be the first under new graduation requirements. Albuquerque Public Schools is in the midst of figuring ...
Mutual Trust Bank PLC (MTB) released its "10th Annual Sustainability Report for 2023", styled "A Decade of Sustainable Commitment", in line with the Global Reporting Initiative (GRI) standards ...
Mutual Trust Bank PLC (MTB) proudly announces the launch of its 10th Annual Sustainability Report for 2023, following the Global Reporting Initiative (GRI) standards. Since 2014, MTB has consistently ...